Maximum Strength Pepcid AC Approval Calls For Postmarketing Study
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson/Merck is required to submit a protocol by late March 2004 for a postmarket study on Pepcid AC (famotidine) (10 mg) and new Maximum Strength Pepcid AC (20 mg), following FDA approval of the latter Sept. 24
You may also be interested in...
Mint Flavor Harvest For OTC Famotidine Pioneer Pepcid AC Follows Two ANDA Competitors
Pepcid AC Maximum Strength (20 mg) in Icy Cool Mint tablets available in 20- and 40-count bottles. Walmart’s Equate and Sanofi’s Zantac 360 famotidine formulations already offer mint flavor options.
J&J/Merck Bolsters Heartburn Lineup With Maximum Strength Pepcid AC
New heartburn prevention/relief product Maximum Strength Pepcid AC will hit shelves Oct. 17, following FDA approval of the new dosage Sept. 24, according to Johnson & Johnson/Merck
Rx-Strength Pepcid Could Join Prilosec OTC In Consumer Market
Johnson & Johnson/Merck is preparing to introduce a prescription strength version of Pepcid (famotidine) for over-the-counter sale